Frontiers | IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
YAP Aggravates Inflammatory Bowel Disease by Regulating M1/M2 Macrophage Polarization and Gut Microbial Homeostasis - ScienceDirect
Frontiers | IL-10 and IL-22 in Mucosal Immunity: Driving Protection and Pathology
Antibody signatures in inflammatory bowel disease: current developments and future applications: Trends in Molecular Medicine
Variation in Interleukin 6 Receptor Gene Associates With Risk of Crohn's Disease and Ulcerative Colitis - ScienceDirect
Serum IL-6 and TNF-α levels of mice with DSS-induced colitis treated... | Download Scientific Diagram
Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study | PLOS ONE
Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells | American Journal of Physiology-Gastrointestinal and Liver Physiology
Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease - ScienceDirect
Translating IL-6 biology into effective treatments | Nature Reviews Rheumatology
Compartmentalized Response of IL-6/STAT3 Signaling in the Colonic Mucosa Mediates Colitis Development | The Journal of Immunology
Compartmentalized Response of IL-6/STAT3 Signaling in the Colonic Mucosa Mediates Colitis Development
Variation in Interleukin 6 Receptor Gene Associates With Risk of Crohn's Disease and Ulcerative Colitis - ScienceDirect
Il‐6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevance - Mudter - 2007 - Inflammatory Bowel Diseases - Wiley Online Library
New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology | Nature Reviews Gastroenterology & Hepatology
Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease | Gut
Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases | SpringerLink
Interleukin-6: obstacles to targeting a complex cytokine in critical illness - The Lancet Respiratory Medicine
ELISA-based quantification of cytokines IL-10 and IL-6 in colon tissues... | Download Scientific Diagram
JCM | Free Full-Text | Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products | HTML
Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease - ScienceDirect
Biotin Supplementation Ameliorates Murine Colitis by Preventing NF-κB Activation - ScienceDirect
Interleukin-6, but not the interleukin-6 receptor plays a role in recovery from dextran sodium sulfate-induced colitis
